ING: Ignore erroneous filing on $1.2B US share sale
March 19, 2014 by Zachary Tracer
(Bloomberg) — ING Groep NV, the biggest Dutch financial-services company, told investors to disregard a regulatory filing that outlined plans to sell more shares in its U.S. life insurance unit.
“It was an error,” Raymond Vermeulen, an ING spokesman, said by phone. “Anything in the filing which says something about what we might be doing should be ignored.”
The U.S. Securities and Exchange Commission filing was posted before 7 a.m. in New York.
Originally Posted at LifeHealthPro on March 18, 2014 by Zachary Tracer.
Categories: Industry Articles